National Institutes of Health
Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing July 17, 2027.
Overview
The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full Funding Opportunity Announcement (FOA), that applications for change of recipient organization status, often referred to in this announcement as Successor-In-Interest, may be…